Mutational landscape of epidermoid carcinoma of the penis in a Brazilian cohort
Renato Mendes Rossi De Lucca , Danielle Barbosa Brotto , Claudia Tarcila Gomes Sares , Kelly Gomes Duarte , Wilson Araujo Silva Junior , Philippe E. Spiess , Shahrokh F. Shariat , Natália Dalsenter Avilez , Caio de Oliveira , Leonardo O. Reis , Rodolfo Borges dos Reis
Exploration of Targeted Anti-tumor Therapy ›› 2025, Vol. 6 ›› Issue (1) : 1002323
Aim: Penile cancer (PeCa) is a rare malignancy strongly associated with poor genital hygiene and is more prevalent in regions with low socioeconomic status. PeCa accounts for approximately 2% to 4% of all male cancers in Brazil, with higher incidence in the North and Northeast regions. Despite its aggressive nature, the molecular mechanisms underlying PeCa remain poorly understood. We performed whole-exome sequencing in a Brazilian cohort of patients with PeCa to identify potentially pathogenic genetic alterations associated with tumor development and progression.
Methods: Tumor tissue samples were obtained from patients diagnosed with PeCa. DNA was extracted and subjected to whole-exome sequencing. Human papillomavirus (HPV) genotyping was performed for subtypes 16 and 18. Control samples were collected from individuals without PeCa or other genital diseases.
Results: The cohort demonstrated considerable genetic heterogeneity. Multiple gene mutations were identified in tumor samples, many of which are involved in carcinogenesis-related biological pathways. Distinct molecular profiles were observed, suggesting diverse tumorigenic mechanisms. MUC16 (present in 11/12 patients, 91.7%) and PABPC1 (8/12 patients, 66.7%) were the most frequently mutated genes. HPV-16 was detected in a subset of cases; however, no consistent association with more aggressive disease was identified.
Conclusions: This study provides new insights into the genomic landscape of PeCa in a Brazilian population. The findings highlight the presence of heterogeneous and potentially pathogenic mutations, reinforcing the need for further molecular characterization and exploration of novel therapeutic targets in PeCa.
Penile cancer / mutations / epidemiology
| [1] |
|
| [2] |
International Agency for Research on Cancer (IARC). Cancer Incidence in Five Continents Volume XII [Internet]. IARC; c2025 [cited 2025 May 1]. Available from: https://publications.iarc.who.int/Book-And-Report-Series/Iarc-Scientific-Publications/Cancer-Incidence-In-Five-Continents-Volume-XII-2024 |
| [3] |
|
| [4] |
World Health Organization. Predictions of the future cancer incidence and mortality burden worldwide up until 2050 [Internet]. IARC; c 1965-2025 [cited 2025 May 1]. Available from: http://gco.iarc.fr/tomorrow/home |
| [5] |
|
| [6] |
Ferreira U, Ribeiro MA, Reis LO, Prudente A, Matheus WE. Sentinel lymph node biopsy in penile cancer: a comparative study using modified inguinal dissection. Int Braz J Urol. 2008; 34: 725-30: discussion 730. |
| [7] |
|
| [8] |
|
| [9] |
|
| [10] |
|
| [11] |
|
| [12] |
|
| [13] |
|
| [14] |
|
| [15] |
|
| [16] |
|
| [17] |
|
| [18] |
|
| [19] |
|
| [20] |
|
| [21] |
|
| [22] |
Agarwal A, Nassar A, Nagy R, Curran C, Abou Alaiwi S, McGregor BA, |
| [23] |
|
| [24] |
|
| [25] |
|
| [26] |
Kusano H, Togashi Y, Akiba J, Moriya F, Baba K, Matsuzaki N, |
| [27] |
|
| [28] |
|
| [29] |
|
| [30] |
|
| [31] |
Yamagishi H, Kuroda H, Imai Y, |
| [32] |
|
| [33] |
|
| [34] |
|
| [35] |
|
| [36] |
|
| [37] |
|
/
| 〈 |
|
〉 |